Using advanced imaging to analyze kidney cancer tissues
Triboelectric Ambient Mass Spectrometry Imaging of Renal Cell Carcinomas
['FUNDING_OTHER'] · GEORGIA INSTITUTE OF TECHNOLOGY · NIH-10932141
This study is testing a new imaging method to better understand kidney cancer by looking closely at the molecules in tumor tissues, which could help doctors find better ways to diagnose and treat patients like you.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | GEORGIA INSTITUTE OF TECHNOLOGY (nih funded) |
| Locations | 1 site (ATLANTA, UNITED STATES) |
| Trial ID | NIH-10932141 on ClinicalTrials.gov |
What this research studies
This research focuses on developing a new imaging technique called Triboelectric Ambient Mass Spectrometry Imaging (TENG MSI) to analyze the molecular composition of clear cell renal carcinoma tissues. By utilizing this innovative method, researchers aim to achieve higher sensitivity in detecting important lipids and metabolites that play a crucial role in kidney cancer. The study will benchmark the performance of TENG MSI against traditional imaging techniques to assess its effectiveness in providing detailed insights into cancer biology. Patients may benefit from improved diagnostic tools that can lead to better treatment strategies based on the molecular characteristics of their tumors.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with clear cell renal carcinoma who are undergoing treatment or monitoring.
Not a fit: Patients with other types of kidney cancer or those not diagnosed with renal cell carcinoma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate diagnostics and personalized treatment options for patients with kidney cancer.
How similar studies have performed: Previous research has shown success with mass spectrometry imaging techniques, indicating potential for this novel approach to yield significant insights.
Where this research is happening
ATLANTA, UNITED STATES
- GEORGIA INSTITUTE OF TECHNOLOGY — ATLANTA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: FERNANDEZ, FACUNDO MARTIN — GEORGIA INSTITUTE OF TECHNOLOGY
- Study coordinator: FERNANDEZ, FACUNDO MARTIN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.